Skip to main content
. 2021 Mar 1;19(4):473–486. doi: 10.1007/s40258-021-00635-7

Table 3.

Additional interventions for adults

First author, year Intervention Mean costs (95% CI)/[SD] Mean outcomes (95% CI)/[SD] Incremental cost (95% CI)/[SD] Incremental effect (95% CI)/[SD] Incremental cost-effectiveness of intervention vs. TAU or BUC CEAC CEP
Meng, 2017 [22] FSM (n = 89) − $864a NR − $64 (− $206 to $77)a 0.014 QALYs (− 0.008 to 0.036)a FSM dominant Y Y
TAU (n = 48) − $569a NR NA NA NA
Richardson, 2013 [24] PR (n = 85) NR NR £218 (− £474 to £911) − 0.012 QALYs (− 0.088 to 0.065) TAU dominates PR Y N
SL (n = 97) NR NR £460 (− £250 to £1169) − 0.042 QALYs (− 0.122 to 0.038) TAU dominates SL
TAU (n = 92) NR NR NA NA NA
Sabes-Figuera 2012, [25] GET (n = 51) £474b 10.06 CFSa £261 (£141 to £382) 1.1 CFS (− 2.3 to 4.4)a £987 per clinically significant improvement in CFS Y N
COUN (n = 58) £651b 8.62 CFSa £423 (£288 to £559) − 0.1 CFS (− 3.1 to 2.9)a BUC dominates COU
BUC (n = 54) £213b 8.56 CFSa NA NA NA

BUC usual care plus self-help booklet, COUN counselling, CFS chronic fatigue syndrome, CI confidence interval, FSM fatigue self-management, GET graded exercise therapy, N no, NA not applicable, NR not reported, PR pragmatic rehabilitation, QALYs quality-adjusted life-years, SD standard deviation, SL supportive listening, TAU treatment as usual, Y yes, CEAC cost-effectiveness acceptability curve, CEP cost-effectiveness plane

aChange in effect/costs from baseline to follow-up

bHealthcare perspective only